CervoMed Inc expected to post a loss of 41 cents a share - Earnings Preview

CervoMed

08/11/2024 16:45

* CervoMed Inc  CRVO.OQ   CRVO.O  is expected to show a rise
in
quarterly revenue when it reports  results on November 11
(estimated) for the period ending September 30 2024
    * The Boston Massachusetts-based  company is expected to
report a
101.0% increase in revenue to $3.067 million from $1.53 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for CervoMed Inc is for a
loss
of 41 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CervoMed
Inc is
63.00​, above​ its last closing price of $12.53. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.26       -0.31      -0.27     Beat    11.8
 Mar. 31 0001  -0.39       -0.39      -0.41     Missed  -5.1
 Dec. 31 2023  -0.29       -0.29      -0.38     Missed  -31​
 Sep. 30 2023  -0.95       -0.95      -0.70     Beat    26.3
 ​​                                                     
                                                        ​
 Sep. 30 2022  -2.97       -3.09      -2.05     Beat    33.5
 This summary was machine generated November 8 at 16:45 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)